Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to DO2003000699ApriorityCriticalpatent/DOP2003000699A/es
Publication of DOP2003000699ApublicationCriticalpatent/DOP2003000699A/es
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
La presente invención se refiere a vacunas de combinación y métodos para tratar o prevenir enfermedades o trastornos en un animal, provocados por la infección con el virus de la diarrea virica bovina (BVDV) de los tipos 1 y 2, el virus del herpes bovino tipo-1 (BHV-1), virus sincitial respiratorio bovino (BRSV), virus de la paraifluenza (pi3), campylobacter fetus, leptospira canicola, leptospira grippotyphosa, leptospira hardjo-prajitno, lestospira icterohaemmorrhagiae, leptospira hardjo-bovis y leptospira Pomona, administrado al animal una cantidad efectiva de una vacuna de combinación. La vacuna de combinación puede ser un preparado inactivado o modificado vivo de células enteras o parciales
DO2003000699A2003-08-222003-08-22Vacunas para enfermedades reproductoras del ganado
DOP2003000699A
(es)
Influence of vaccination with a combined chemically altered/inactivated BHV-1/BVD vaccine or a modified-live BHV-1/BVD vaccine on reproductive performance in beef cows and heifers
Comparison of the BVDV, BHV-1, and BRSV anamnestic response to modified-live or inactivated vaccines in calves previously vaccinated with a modified-live virus vaccine.
Evaluation of vaccination and antimicrobial protocols in nursery pigs coinfected with porcine reproductive and respiratory syndrome virus and Streptococcus suis